Abstract
Background: Central precocious puberty occurs in 0.2 % of young girls and is officially defined as the presence of pubertal signs or characteristics in girls under the age of 7 years. This condition occurs as a result of early activation of the hypothalamic pituitary axis. The most common type is idiopathic, although this is diagnosis of exclusion. Purpose: To alert providers about the warning signs and when to intervene as if left untreated, central precocious puberty will result in progressive sexual characteristic development, early menstrual onset and rapid skeletal maturation, resulting in early epiphyseal stimulation. Conclusions: Central precocious puberty is an important condition to recognize. It is important to screen when advanced pubertal characteristics are seen under age 7 years. Once idiopathic precocious puberty has been confirmed there are many options for treatment with good long-term outcomes, which allow for attainment of predicted genetic height.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Loomba-Albrecht LA, Styne DA. The physiology of puberty and its disorders. Pediatr Ann. 2012;41(4):e1–9.
Sorensen K, Mouritsen A, Aksglaede L, Hagen CP, Mogensen SS, Juul A. Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty. Horm Res Pediatr. 2012;77:137–45.
Sperling M, editor. Pediatric endocrinology. 3rd ed. Philadelphia: Saunders; 2008. p. 530–609.
Ucar A, Saka N, Bas F, Bundak R, Gunoz H, Darendeliler F. Is premature thelarche in the first two years of life transient? J Clin Res Pediatr Endocrinol. 2012;4(3):140–5.
Lee PA. Central precocious puberty: an overview of diagnosis, treatment and outcome. Endocrinol Metab Clin North Am. 1999;28(4):901–18.
Martin DD, Meister K, Schwiezer R, Ranke MB, Thodberg HH, Binder G. Validation of automatic bone age rating in children with precocious and early puberty. J Pediatr Endocrinol Metab. 2011;24(11–12):1009–14.
Houk CP, Kunselman AR, Lee PA. Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls. Pediatrics. 2009;123:e1059–63.
Kilic A, et al. Clinical and laboratory characteristics of children referred for early puberty: preponderance in 7-8 years of age. J Clin Res Pediatr Endocrinol. 2012;4(4):208–12.
Sathavisam A, Rosenberg HK, Shapiro S, Wang H, Rapaport R. Pelvic ultrasonography in the evaluation of central precocious puberty: comparison with leuprolide stimulation test. J Pediatr. 2011;159(3):490–5.
Fritz M, Speroff L, editors. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 391–434.
Emans SJ, Laufer MR, Goldstein DP, editors. Pediatric and adolescent gynecology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 156–80.
Sanfilippo JS, Muram D, Dewhurst J, Lee PA, editors. Pediatric and adolescent gynecology. 2nd ed. Philadelphia: W.B. Saunders; 2001. p. 59–71.
Chi CH, Durham E, Neely EK. Pharmacodynamics of aqueous leuprolide acetate stimulation testing in girls: correlation between clinical diagnosis and time of peak luteining hormone level. J Pediatr. 2012;161(4):757–9.
Prasad HK, Khadilkar VV, Jahagirdar R, Khadilkar AV, Lalwani SK. Evaluation of GnRH analogue testing in diagnosis and management of children with pubertal disorders. Indian J Endocrinol Metab. 2012;16(3):400–5.
Sathasivam A, Garibaldi L, Shapiro S, Godbold J, Rapaport R. Leuprolide stimulation testing for the evaluation of early sexual maturation. Clin Endocrinol. 2010;73:375–81.
Allali S, Lemaire P, Couto-Silva AC, Prete G, Trivin C, Brauner R. Predicting the adult height of girls with central precocious puberty. Med Sci Monit. 2011;17(6):41–8.
Ko JH, Lee HS, Kim SM, Hwang JS. Changes in bone mineral density and body composition in children with central precocious puberty and early puberty before and after one year of treatment with GnRH agonist. Horm Res Paediatr. 2011;75(3):174–9.
Eugster EA, et al. Efficacy of histrelin subdermal implant in children with central precocious puberty: a multicenter trial. J Clin Endocrinol Metab. 2007;92(5):1697–704.
Kim EY, Lee MI. Psychosocial aspects in girls with idiopathic precocious puberty. Psychiatry Investig. 2012;9(1):25–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Dietrich, J.E. (2014). Central Precocious Puberty. In: Dietrich, J. (eds) Female Puberty. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0912-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0912-4_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0911-7
Online ISBN: 978-1-4939-0912-4
eBook Packages: MedicineMedicine (R0)